TraceLink ISO 42001 Certification Validates AI Governance for Pharma Supply Chains

TraceLink earned the ISO/IEC 42001:2023 certification for its Artificial Intelligence Management System, passing an audit by A-LIGN with zero nonconformances or improvement areas flagged. The standard, published in 2023, is the first international framework for governing AI systems. For TraceLink's customers in regulated life sciences and healthcare, the certification provides documented assurance that the company's OPUS Agents operate under defined oversight, risk controls, and human accountability.

A simple read: the certification proves TraceLink meets an emerging compliance baseline for AI software. The better market read is narrower. ISO 42001 is not a product safety certification. It applies to the management system behind the AI, not to the models or agents themselves. TraceLink's CEO Shabbir Dahod made that distinction explicit: the standard helps ensure "appropriate oversight, risk management, and human accountability." For life sciences companies moving AI agents into production supply chains, that governance layer is the difference between a pilot and a regulated deployment.

The certification covers the OPUS Platform and OPUS Agents, which are governed digital teammates that execute tasks as permissioned users across multi-enterprise processes. Unlike AI that runs inside a single company's systems, agentic work in supply chains requires coordination across trading partners, business transactions, and regulated processes. The governance problem compounds. TraceLink's chief information security officer Dan Nelson said the certification reinforces "strong controls, clear accountability, and a risk-based approach" for customers who need confidence that AI systems stay within defined permissions and policies.